Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome　― The ODYSSEY J-IVUS Trial ―-Reference-Cited by-同舟云学术

Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome　― The ODYSSEY J-IVUS Trial ―

Published:2019-09-25 Issue:10 Volume:83 Page:2025-2033
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Ako Junya¹,Hibi Kiyoshi²,Tsujita Kenichi³,Hiro Takafumi⁴,Morino Yoshihiro⁵,Kozuma Ken⁶,Shinke Toshiro⁷,Otake Hiromasa⁸,Uno Kiyoko⁹,Louie Michael J¹⁰,Takagi Yoshiharu¹¹,Miyauchi Katsumi¹²

Affiliation:

1. Department of Cardiovascular Medicine, Kitasato University School of Medicine

2. Division of Cardiology, Yokohama City University Medical Center

3. Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University

4. Division of Cardiology, Department of Medicine, Nihon University School of Medicine

5. Division of Cardiology, Department of Internal Medicine, Iwate Medical University

6. Division of Cardiology, Teikyo University Hospital

7. Division of Cardiovascular Medicine, Department of Internal Medicine, Showa University School of Medicine

8. Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine

9. Cardiovascular Medical, Sanofi

10. Regeneron Pharmaceuticals, Inc.

11. Clinical Sciences and Operations, Sanofi

12. Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/83/10/83_CJ-19-0412/_pdf

Reference20 articles.

1. 1. Pilgrim T, Vranckx P, Valgimigli M, Stefanini GG, Piccolo R, Rat J, et al. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction. Am Heart J 2016; 175: 56–65.

2. 2. Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post-myocardial infarction patients: Nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J 2015; 36: 1163–1170.

3. 3. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61: e179–e347.

4. 4. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 2014; 64: e139.

5. 5. Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL, et al. 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol 2017; 70: 2048–2090.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature;Drugs;2024-01-25

2. Atherosclerotic plaque stabilization and regression: a review of clinical evidence;Nature Reviews Cardiology;2024-01-04

3. Novel Biomarkers of Cardiovascular Disease;Comprehensive Precision Medicine;2024

4. Safety and Efficacy of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors After Acute Coronary Syndrome: A Meta-analysis of Randomized Controlled Trials;American Journal of Cardiovascular Drugs;2024-01

5. Effect of PCSK9 antibodies on coronary plaque regression and stabilization derived from intravascular imaging in patients with coronary artery disease: A meta-analysis;International Journal of Cardiology;2023-12